MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea
· Delayed Price · Currency is KRW 1,591.00
+12.00 (0.76%)
Last updated: Apr 17, 2025
MYUNGMOON Pharm co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 186,443 | 169,567 | 152,135 | 137,760 | 127,853 | Upgrade
|
| Other Revenue | - | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 186,443 | 169,567 | 152,135 | 137,760 | 127,853 | Upgrade
|
| Revenue Growth (YoY) | 9.95% | 11.46% | 10.44% | 7.75% | -14.39% | Upgrade
|
| Cost of Revenue | 81,949 | 74,658 | 74,528 | 75,965 | 82,658 | Upgrade
|
| Gross Profit | 104,494 | 94,909 | 77,607 | 61,795 | 45,195 | Upgrade
|
| Selling, General & Admin | 100,698 | 90,417 | 66,846 | 66,213 | 68,191 | Upgrade
|
| Research & Development | 2,059 | 2,970 | 1,711 | 2,065 | 535.06 | Upgrade
|
| Other Operating Expenses | 1,344 | 1,358 | 1,365 | 1,506 | 4,908 | Upgrade
|
| Operating Expenses | 102,565 | 93,946 | 71,173 | 67,675 | 74,159 | Upgrade
|
| Operating Income | 1,929 | 963.77 | 6,434 | -5,881 | -28,964 | Upgrade
|
| Interest Expense | -5,352 | -5,137 | -3,735 | -3,042 | -4,142 | Upgrade
|
| Interest & Investment Income | 109.68 | 225.05 | 152.17 | 199.05 | 215.75 | Upgrade
|
| Currency Exchange Gain (Loss) | 45.93 | 46 | -0.77 | 17.34 | 0.39 | Upgrade
|
| Other Non Operating Income (Expenses) | 826.22 | -132.13 | -275.32 | 1,163 | 3,768 | Upgrade
|
| EBT Excluding Unusual Items | -2,441 | -4,035 | 2,575 | -7,543 | -29,122 | Upgrade
|
| Gain (Loss) on Sale of Investments | 63.24 | -36.24 | 95.02 | 498.6 | 1,892 | Upgrade
|
| Gain (Loss) on Sale of Assets | -512.21 | 25.61 | -14.03 | 895.37 | -30.58 | Upgrade
|
| Asset Writedown | -854.35 | -736.22 | -4.2 | -448.76 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -34.27 | Upgrade
|
| Pretax Income | -3,744 | -4,782 | 2,652 | -6,598 | -27,295 | Upgrade
|
| Income Tax Expense | 45.4 | 92.61 | -5,324 | 206.14 | 458.5 | Upgrade
|
| Earnings From Continuing Operations | -3,790 | -4,874 | 7,976 | -6,804 | -27,753 | Upgrade
|
| Minority Interest in Earnings | 755.39 | 349.41 | -108.07 | -60.25 | 114.43 | Upgrade
|
| Net Income | -3,035 | -4,525 | 7,868 | -6,865 | -27,639 | Upgrade
|
| Net Income to Common | -3,035 | -4,525 | 7,868 | -6,865 | -27,639 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 34 | 34 | 34 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 34 | 34 | 34 | 29 | Upgrade
|
| Shares Change (YoY) | -0.58% | -0.38% | - | 15.48% | 20.01% | Upgrade
|
| EPS (Basic) | -90.62 | -134.35 | 232.74 | -203.06 | -944.14 | Upgrade
|
| EPS (Diluted) | -91.00 | -134.35 | 232.74 | -203.06 | -944.14 | Upgrade
|
| Free Cash Flow | -2,109 | -8,164 | 3,744 | 480.28 | -18,681 | Upgrade
|
| Free Cash Flow Per Share | -62.99 | -242.39 | 110.75 | 14.21 | -638.16 | Upgrade
|
| Gross Margin | 56.05% | 55.97% | 51.01% | 44.86% | 35.35% | Upgrade
|
| Operating Margin | 1.03% | 0.57% | 4.23% | -4.27% | -22.65% | Upgrade
|
| Profit Margin | -1.63% | -2.67% | 5.17% | -4.98% | -21.62% | Upgrade
|
| Free Cash Flow Margin | -1.13% | -4.81% | 2.46% | 0.35% | -14.61% | Upgrade
|
| EBITDA | 5,994 | 5,132 | 10,672 | -1,678 | -24,763 | Upgrade
|
| EBITDA Margin | 3.21% | 3.03% | 7.02% | -1.22% | -19.37% | Upgrade
|
| D&A For EBITDA | 4,066 | 4,168 | 4,238 | 4,203 | 4,201 | Upgrade
|
| EBIT | 1,929 | 963.77 | 6,434 | -5,881 | -28,964 | Upgrade
|
| EBIT Margin | 1.03% | 0.57% | 4.23% | -4.27% | -22.65% | Upgrade
|
| Advertising Expenses | 1,348 | 1,372 | 1,314 | 993.55 | 5,906 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.